research and development

Showing 15 posts of 209 posts found.

Phillipe Lutz joins Telormedix

May 13, 2010
Research and Development appointment, research and development, telormedix

Swiss clinical stage biopharmaceutical company Telormedix has appointed Phillipe Lutz chief financial officer. He joins the company from Synosia Therapeutics, …

Patrick-Vallance

GSK appoints Patrick Vallance

May 12, 2010
Research and Development GSK, appointment, research and development

Patrick Vallance has been appointed as senior vice president, medicines discovery and development at GlaxoSmithKline, and as a member of …

Synexus appoints Germany and Poland managers

May 11, 2010
Research and Development CRO, Synexus, appointment, research and development

Synexus has appointed Dr Helena Sigal as country manager for Germany and Radoslaw Janiak as country manager for Poland. Helena …

Professor Sander van Deventer appointed to AMT supervisory board

May 10, 2010
Research and Development AMT, Amsterdam Molecular Therapeutics, appointment, research and development

Dutch human gene therapy company Amsterdam Molecular Therapeutics has appointed Professor Sander van Deventer to its supervisory board. One of …

Frazier

Merck separates president role, appoints Kenneth Frazier

April 30, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Merck & Co, appointment, manufacturing and production, research and development, sales and marketing

Merck & Co has partially split the joint roles of chairman, chief executive and president currently held by Richard Clark, …

US pharma execs join Algeta board

April 29, 2010
Research and Development Algeta, appointment, research and development

Oslo-based oncology company Algeta has added Judith Hemberger and Kapil Dhingra to its board of directors. Judith Hemberger has more …

BayerJogReinhardt

Bayer lures Novartis’ Reinhardt for top healthcare post

April 22, 2010
Research and Development, Sales and Marketing Bayer, appointment, research and development, sales and marketing

German pharma company Bayer has ended its search for someone to replace healthcare chief executive Arthur Higgins, appointing Dr Jörg …

Action Pharma appoints new chief executive

April 19, 2010
Research and Development Action Pharma, appointment, research and development

Ingelise Saunders has joined Danish biotech Action Pharma as its new chief executive. She will be involved in seeking partners …

AquapharmSimonBest

Dr Simon Best joins Aquapharm as chief executive

April 13, 2010
Research and Development Aquapharm, Aquapharm Biodiscovery, appointment, research and development

Aquapharm has appointed Dr Simon Best (pictured) chief executive in a move that sees the Scottish marine biotechnology company’s current …

RochePitzer

Frank Pitzer made chief executive at NimbleGen

April 7, 2010
Research and Development NimbleGen, Roche, appointment, research and development

Roche has promoted Dr Frank Pitzer to chief executive for its Madison, US headquartered genomics business NimbleGen. Dr Pitzer has …

SirJamesBlack

Obituary: Sir James Black

April 6, 2010
Research and Development appointment, research and development

Sir James Black, the British physician and pharmacologist who discovered some of the biggest breakthroughs in medicine in the 20th …

Cordis appoints Christian Spaulding

March 30, 2010
Cordis, Johnson & Johnson, appointment, research and development

Johnson & Johnson’s vascular technology company Cordis has appointed Dr Christian Spaulding worldwide VP of medical affairs. He assumes the …

Pfizer’s Kindler elected PhRMA chairman

March 22, 2010
Research and Development, Sales and Marketing PhRMA, appointment, research and development, sales and marketing

Jeffrey Kindler, chairman and chief executive of Pfizer, has been elected chairman of PhRMA, succeeding AstraZeneca’s chief executive David Brennan …

Talking Point: Responding to trial emergencies

March 19, 2010
Research and Development Talking Point, Talking R&D, research and development

Patients taking part in a clinical trial will sometimes experience a medical emergency, at which point the potential need to …

William Burns

Bill Burns joins Shire board

March 17, 2010
Research and Development, Sales and Marketing Shire, appointment, research and development, sales and marketing

Former Roche pharma chief executive Bill Burns has joined the board at Shire as a non-executive director. Burns has also …

The Gateway to Local Adoption Series

Latest content